Transarterial chemoembolisation (TACE)

PROCEDURE3 trials

Sponsors

Hoffmann-La Roche, Medical University of Vienna, Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Conditions

Hepatocellular CarcinomaHepatocellular Carcinoma (HCC)Liver Cancer

Phase 1

Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma

CompletedNCT00768937

Medical University of ViennaHepatocellular Carcinoma

Start: 2008-09-30End: 2010-11-30Target: 22Updated: 2010-11-09

Phase 2

A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer

CompletedNCT00576199

Hoffmann-La RocheLiver Cancer

Start: 2008-02-29End: 2011-05-31Updated: 2014-08-29

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

CompletedNCT03753659

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestHepatocellular Carcinoma (HCC)

Start: 2019-05-09End: 2024-04-30Updated: 2026-03-23

Related Papers

IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)—The IKF-IMMULAB trial.

Journal of Clinical Oncology2025-01-27

IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2023-01-244 citations

The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2021-05-203 citations